TP53 and leukemia: One clinician-researcher voiced that patients may feel distressed by the information found in the portal and its potential implications for their prognosis: “If I have a thirty year old who is p53 mutated, he is going to know that he has got a bad leukemia, but I’m not so sure that clicking, having a portal link and seeing exactly how bad it is, is super helpful” (CR4).